N, T., A, M., A, C., M, R., V, B., MM, K., & HA, S. (2020). Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]. Dove Medical Press.
Style de citation Chicago (17e éd.)N, Tahir, Madni A, Correia A, Rehman M, Balasubramanian V, Khan MM, et Santos HA. Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]. Dove Medical Press, 2020.
Style de citation MLA (8e éd.)N, Tahir, et al. Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]. Dove Medical Press, 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.